Ceftazidime pharmacokinetics in preterm newborns on the first day of life.
Biol Res Pregnancy Perinatol
; 7(2): 71-3, 1986.
Article
em En
| MEDLINE
| ID: mdl-3524697
ABSTRACT
Ceftazidime pharmacokinetics were studied in 13 preterm newborns requiring antibiotic treatment, following intramuscular administration of a 50 mg/kg dose in the first 24 hours of life. The main pharmacokinetic parameters (peak concentration, time to reach peak, plasma half-life, area under the curve, elimination constant, distribution volume and plasma clearance) were determined directly from the serum concentrations observed. The clinical and bacteriological response to ceftazidime treatment was good; no side effects or alterations of biohumoral parameters were noted.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Recém-Nascido Prematuro
/
Ceftazidima
Idioma:
En
Ano de publicação:
1986
Tipo de documento:
Article